FDA Inspection 1148863 — Bret Fisher, MD
The FDA completed an inspection of Bret Fisher, MD on August 5, 2021 in Panama City, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 5, 2021
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Panama City, FL (United States)
Additional Details
Clinical Investigator (CI)